10.1 Point-of-Care Testing Specimens

10.1 Point-of-Care Testing Specimens

Quick Answer: Point-of-care testing (POCT) brings selected assays to the bedside or clinic. Even CLIA-waived tests such as glucose meters require trained, competent operators, passing quality control, correct specimen collection, complete documentation, and knowing when a result must be confirmed or sent to the central laboratory.

Work Area II of the AMT RPT content outline includes point-of-care testing (POCT) specimens (II-H). As a phlebotomy technician, you may collect capillary blood for a glucose meter, assist with urine dipstick testing, or transport POCT supplies—but you must never perform testing you are not authorized and competent to run. POCT is fast, but preanalytical mistakes at the bedside cause the same patient harm as errors in the main laboratory.

What Is POCT?

Point-of-care testing is any analytic testing performed outside the central laboratory, close to the patient. The specimen is usually collected and tested in the same clinical encounter—often within minutes.

Common POCT examples you will encounter:

• Blood glucose monitoring (capillary fingerstick or heelstick)
• Urine dipstick urinalysis and urine pregnancy (hCG) tests
• Fecal occult blood cards
• Rapid strep, influenza, RSV, or COVID antigen swabs
• Coagulation meters (PT/INR) in anticoagulation clinics
• Arterial blood gas analyzers in critical care (typically not waived)

POCT is not defined by simplicity alone. Complexity depends on the FDA device classification and the site's CLIA certificate. A waived glucose meter still demands discipline; a moderate-complexity blood gas analyzer demands stricter personnel, QC, and proficiency testing.

CLIA-Waived Testing in Context

The Clinical Laboratory Improvement Amendments (CLIA) sort tests into three complexity categories — waived, moderate, and high (PPM is a subset of moderate, and "Certificate for PPM Procedures" is a certificate type rather than a complexity level). Waived tests are simple examinations with an insignificant risk of an erroneous result when the manufacturer's instructions are followed.

Under CLIA itself, a Certificate-of-Waiver site has only two hard obligations:

1. Hold an appropriate CLIA certificate for the tests performed
2. Follow the instructions for use (IFU) exactly—sample type, timing, operating temperature, strip storage, QC intervals

Everything else you will see in a real hospital comes from accreditation and facility policy, not from CLIA's waived-testing rules:

1. Train operators and document competency before independent testing (CAP, The Joint Commission)
2. Maintain records of results, QC, and corrective actions
3. Notify state agencies of certificate changes when required

Know the distinction: deviating from the IFU strips a test of its waived status and reclassifies it as high complexity, which is a CLIA problem. Skipping a competency signature is an accreditation problem.

Waived status does not mean "anyone can test without training." It means the method is simple enough that strict central-lab personnel rules are relaxed—not that bedside shortcuts are acceptable.

Collecting Capillary Specimens for Glucose Meters

Fingerstick glucose is the classic POCT collection skill tied to phlebotomy practice:

1. Verify identity with two unique identifiers; confirm the ordered test.
2. Check the meter and strips—correct model match, in-date, stored at labeled temperature, lot numbers recorded when policy requires.
3. Perform hand hygiene; don gloves.
4. Select the site—lateral fingertip is standard for adults; avoid infected, edematous, or scarred sites. Neonatal heelsticks and alternate forearm sites require device clearance and facility policy—do not assume adult IFU applies.
5. Cleanse with alcohol and allow the site to air dry completely. Wet alcohol dilutes the blood drop and can falsely alter glucose readings.
6. Puncture with an approved single-use lancet device at the correct depth.
7. Wipe away the first drop if the IFU requires a second drop of clean capillary blood.
8. Apply an adequate drop to the strip or test port without excessive milking—squeezing the finger forces tissue fluid into the sample and can falsely lower glucose.
9. Dispose of sharps in a sharps container; apply pressure and bandage.
10. Read, verify, and record the result with units, date/time, and operator identification.

Other common POCT collections

• Urine dipstick / pregnancy: Use clean-catch or random urine in a clean container; read at the exact timed interval in the IFU; do not interpret early or late.
• Occult blood cards: Apply thin smears to designated windows; follow developer timing and diet/medication restrictions on the kit.
• Rapid throat/nasal swabs: Swab the correct anatomical site with adequate rotation time; inadequate sampling causes false negatives.

Operator Competency

Testing must not begin until the operator is trained on that specific device model at that site. Competency assessment methods include direct observation, written tests, blind specimens, and documented QC performance.

Typical competency schedules (facility and accreditation may be stricter):

If your middleware login, badge authorization, or competency record expires, stop testing until renewal. Never use another operator's credentials. POCT coordinators often manage annual demonstrations, QC-based reauthorization, and lockouts on networked meters.

Quality Control and Device Care

Quality control (QC) verifies that the device and reagents perform within expected limits before patient results are trusted. Follow the IFU and site procedure for liquid QC, electronic checks, or onboard QC:

• Run QC at required intervals—commonly each day of patient testing, with each new vial of strips, after device impact, or after maintenance (policy-specific)
• Document QC with date, time, lot numbers, target ranges, and operator ID
• If QC fails, do not test patients. Troubleshoot, repeat QC, remove the device from service, and use a backup in-control meter or send a laboratory glucose specimen
• Store strips in original containers, capped, at labeled temperatures; never use expired, discolored, or heat-damaged strips
• Clean meters with approved disinfectants that will not damage optics, ports, or strip contacts

Critical POCT values—severe hypo- or hyperglycemia, unexpected pregnancy results, dangerous INR readings—require immediate clinical notification with read-back documentation, the same seriousness as central-lab critical values.

When to Send to the Central Laboratory

POCT is appropriate when speed and bedside access matter. Send a specimen to the central laboratory (or use central-lab methodology) when:

When in doubt, escalate to nursing, the POCT coordinator, or the laboratory before acting on a questionable bedside result. Speed never outweighs validity.

Documentation Requirements

A reportable POCT result typically requires:

• Two patient identifiers matching the order
• Test name and numeric or qualitative result with units when applicable
• Date and time of collection/testing
• Operator identification (individual, not shared login)
• Device and reagent lot and expiration when policy requires
• QC pass associated with that testing episode when required
• Critical value notification details (who was notified, time, read-back)

Never chart another person's unattended result as your own. Incomplete documentation breaks the QA trail and can invalidate results in audits or litigation.

Preanalytical Traps Unique to POCT

Exam Focus

Connect waived status with "follow the manufacturer's instructions," insist on competency and QC before patient testing, and recognize collection technique as the dominant POCT error source. When glucose QC fails, the correct answer is to stop patient testing until the system is back in control or the specimen goes to the laboratory.